Efficacy of telithromycin (HMR 3647) against enterococci in a mouse peritonitis model

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3434-3437

  Singh, K V ^a   Zscheck, K K ^a   Murray, B E ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; TELITHROMYCIN;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIVITY; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PERITONITIS; PRIORITY JOURNAL; STRAIN DIFFERENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; ERYTHROMYCIN; KETOLIDES; MACROLIDES; MICE; MICROBIAL SENSITIVITY TESTS; PERITONITIS;

EID: 0034425840     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3434-3437.2000     Document Type: Article

References (25)

1. Antibacterial activity of RU 64004 (HMR 3004), a novel ketolide derivative active against respiratory pathogens
2. Resistance of Enterococcus faecium to neutrophil-mediated phagocytosis
3. The in vitro activity of HMR 3647, a new ketolide antimicrobial agent
4. Emerging resistance to antimicrobial agents in gram-positive bacteria
5. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology
6. In vitro activity of the ketolide HMR 3647 (RU 6647) for Legionella spp., its pharmacokinetics in guinea pigs, and use of the drug to treat guinea pigs with Legionella pneumophila pneumonia
7. Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis
8. The bactericidal activities of HMR 3647 and erythromycin against gram-positive bacilli and development of resistance
9. Investigation of the reformulated Remel Synergy Quad plate for detection of high-level aminoglycoside and vancomycin resistance among enterococci
10. Use of lymphokines in treatment of experimental intra-abdominal abscess caused by Bacteroides fragilis
11. Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit
12. Diversity among multidrug-resistant enterococci
13. The life and times of the enterococcus
14. Transferable β-lactamase: A new mechanism for in vitro penicillin resistance in Streptococcus faecalis
15. Generation of restriction map of Enterococcus faecalis OG1 and investigation of growth requirements and regions encoding biosynthetic function
16. Ketolide treatment of Haemophilus influenzae experimental pneumonia
17. Nosocomial bloodstream infections: Secular trends in rates, mortality, and contribution to hospital deaths
18. A simple method of estimating fifty percent endpoints
19. In-vitro susceptibility studies of vancomycinresistant Enterococcus faecalis
20. Major trends in the microbial etiology of nosocomial infection
21. In vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria
22. Generation and testing of mutants of Enterococcus faecalis in a mouse peritonitis model
23. Enterococci